BackBeam Therapeutics Overview
Beam Therapeutics Inc

Beam Therapeutics Target Price

Analysts' 12-month price predictions for BEAM.

Share Price

$16.76

Average Target Price

$40.00138.7% upside

2 analysts in the last 4 months

High: $55 | Low: $25

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2025-05-07GuggenheimDebjit Chattopadhyay$55228.2% upsideOpen
2025-03-03Scotiabank$2549.2% upsideOpen
2025-01-07Tudor PickeringWilliam Pickering$37120.8% upsideOpen
2024-11-06Leerink PartnersRick Bienkowski$39132.7% upsideOpen
2024-11-05BMO CapitalKostas Biliouris$57240.1% upsideOpen
2024-09-11Stifel NicolausBenjamin Burnett$69311.7% upsideOpen
2023-02-01Cantor Fitzgerald$62269.9% upsideOpen
2022-12-20BMO CapitalKostas Biliouris$66293.8% upsideOpen
2022-12-13Citigroup$62269.9% upsideOpen
2022-04-28Credit Suisse$62269.9% upsideOpen